BC is a diverse tumour; based on the hormone receptors (ER and PR) and HER2 (ERBB2) signatures, BC is clinically classified into three main subtypes: TNBC, tubular ER+ and PR+, and HER2+ [3, 70, 71]. This evidence concerns the gene ERBB2 and breast cancer.